BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33933000)

  • 1. Oxytocin ameliorates impaired social behavior in a Chd8 haploinsufficiency mouse model of autism.
    Cherepanov SM; Gerasimenko M; Yuhi T; Furuhara K; Tsuji C; Yokoyama S; Nakayama KI; Nishiyama M; Higashida H
    BMC Neurosci; 2021 May; 22(1):32. PubMed ID: 33933000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHD8 haploinsufficiency results in autistic-like phenotypes in mice.
    Katayama Y; Nishiyama M; Shoji H; Ohkawa Y; Kawamura A; Sato T; Suyama M; Takumi T; Miyakawa T; Nakayama KI
    Nature; 2016 Sep; 537(7622):675-679. PubMed ID: 27602517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism.
    Meziane H; Schaller F; Bauer S; Villard C; Matarazzo V; Riet F; Guillon G; Lafitte D; Desarmenien MG; Tauber M; Muscatelli F
    Biol Psychiatry; 2015 Jul; 78(2):85-94. PubMed ID: 25599930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies.
    Modi ME; Young LJ
    Horm Behav; 2012 Mar; 61(3):340-50. PubMed ID: 22206823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term exposure to intranasal oxytocin in a mouse autism model.
    Bales KL; Solomon M; Jacob S; Crawley JN; Silverman JL; Larke RH; Sahagun E; Puhger KR; Pride MC; Mendoza SP
    Transl Psychiatry; 2014 Nov; 4(11):e480. PubMed ID: 25386957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodendrocyte dysfunction due to Chd8 mutation gives rise to behavioral deficits in mice.
    Kawamura A; Katayama Y; Nishiyama M; Shoji H; Tokuoka K; Ueta Y; Miyata M; Isa T; Miyakawa T; Hayashi-Takagi A; Nakayama KI
    Hum Mol Genet; 2020 May; 29(8):1274-1291. PubMed ID: 32142125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Chd8 Mutant Mouse Displays Altered Ultrasonic Vocalizations and Enhanced Motor Coordination.
    Hulbert SW; Wang X; Gbadegesin SO; Xu Q; Xu X; Jiang YH
    Autism Res; 2020 Oct; 13(10):1685-1697. PubMed ID: 32815320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chd8 haploinsufficiency impairs early brain development and protein homeostasis later in life.
    Jiménez JA; Ptacek TS; Tuttle AH; Schmid RS; Moy SS; Simon JM; Zylka MJ
    Mol Autism; 2020 Oct; 11(1):74. PubMed ID: 33023670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arid1b Haploinsufficiency Causes Abnormal Brain Gene Expression and Autism-Related Behaviors in Mice.
    Shibutani M; Horii T; Shoji H; Morita S; Kimura M; Terawaki N; Miyakawa T; Hatada I
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal oxytocin administration ameliorates social behavioral deficits in a POGZ
    Kitagawa K; Matsumura K; Baba M; Kondo M; Takemoto T; Nagayasu K; Ago Y; Seiriki K; Hayata-Takano A; Kasai A; Takuma K; Hashimoto R; Hashimoto H; Nakazawa T
    Mol Brain; 2021 Mar; 14(1):56. PubMed ID: 33726803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHD8 regulates gut epithelial cell function and affects autism-related behaviors through the gut-brain axis.
    Chatterjee I; Getselter D; Ghanayem N; Harari R; Davis L; Bel S; Elliott E
    Transl Psychiatry; 2023 Oct; 13(1):305. PubMed ID: 37783686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of the autism-related gene Chd8 alters activity-dependent transcriptional responses in mouse postmitotic neurons.
    Kawamura A; Nishiyama M
    Commun Biol; 2023 Jun; 6(1):593. PubMed ID: 37268684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental pyrethroid exposure and age influence phenotypes in a Chd8 haploinsufficient autism mouse model.
    Jiménez JA; Simon JM; Hu W; Moy SS; Harper KM; Liu CW; Lu K; Zylka MJ
    Sci Rep; 2022 Apr; 12(1):5555. PubMed ID: 35365720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHD8 haploinsufficiency links autism to transient alterations in excitatory and inhibitory trajectories.
    Villa CE; Cheroni C; Dotter CP; López-Tóbon A; Oliveira B; Sacco R; Yahya AÇ; Morandell J; Gabriele M; Tavakoli MR; Lyudchik J; Sommer C; Gabitto M; Danzl JG; Testa G; Novarino G
    Cell Rep; 2022 Apr; 39(1):110615. PubMed ID: 35385734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The autism-associated protein CHD8 is required for cerebellar development and motor function.
    Kawamura A; Katayama Y; Kakegawa W; Ino D; Nishiyama M; Yuzaki M; Nakayama KI
    Cell Rep; 2021 Apr; 35(1):108932. PubMed ID: 33826902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct, dosage-sensitive requirements for the autism-associated factor CHD8 during cortical development.
    Hurley S; Mohan C; Suetterlin P; Ellingford R; Riegman KLH; Ellegood J; Caruso A; Michetti C; Brock O; Evans R; Rudari F; Delogu A; Scattoni ML; Lerch JP; Fernandes C; Basson MA
    Mol Autism; 2021 Feb; 12(1):16. PubMed ID: 33627187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous deletion of the autism-associated gene CHD8 impairs synaptic function through widespread changes in gene expression and chromatin compaction.
    Shi X; Lu C; Corman A; Nikish A; Zhou Y; Platt RJ; Iossifov I; Zhang F; Pan JQ; Sanjana NE
    Am J Hum Genet; 2023 Oct; 110(10):1750-1768. PubMed ID: 37802044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autism-associated CHD8 keeps proliferation of human neural progenitors in check by lengthening the G1 phase of the cell cycle.
    Coakley-Youngs E; Ranatunga M; Richardson S; Getti G; Shorter S; Fivaz M
    Biol Open; 2022 Sep; 11(9):. PubMed ID: 36222238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effects of oxytocin in autism: Current status of the research].
    Gauthier C; Doyen C; Amado I; Lôo H; Gaillard R
    Encephale; 2016 Feb; 42(1):24-31. PubMed ID: 26797566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal oxytocin as a treatment for anxiety and autism: From subclinical to clinical applications.
    Yin H; Jiang M; Han T; Xu X
    Peptides; 2024 Jun; 176():171211. PubMed ID: 38579916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.